Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Market capitalization
4.24 MUSD
—
—
−19.18USD
−30.86 MUSD
—
2.06 M
Beta (1Y)
4.00
About Genprex, Inc.
Sector
CEO
Ryan M. Confer
Headquarters
Austin
Website
Employees (FY)
26
Founded
2009
FIGI
BBG00F7T0157
Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
0.00
GNPXNice pop impulse recently. Most resiatnce I see is around 4$. As of now holding some solid support based off my favorite indicators. If w can pop 2.88 and hold should see another run. Don’t think it’s over yet, cpuldBe just the beginning. 1 hour potential double bottom. Stops below 2.50$
Long
$GNPX Target PTs 7 and higherGenprex Receives U.S. FDA Fast Track Designation for REQORSA™️ Immunogene Therapy in Combination With Keytruda®️ for the Treatment of Non-Small Cell Lung CancerSecond FDA Fast Track Designation Further Validates the Potential of REQORSAAUSTIN, Texas, January 03, 2022--(BUSINESS WIRE)--Genprex, I
Long
Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ ImGNPX: Genprex, Inc.2022-01-03 08:00:00Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer
Long
11
GNPXMID-TERM: Trying to hold a support with potential classic bullish divergence on the 4hr and potential hidden bullish divergence on the daily, if it pivots here. (not financial advice)
Long
GNPX: potential gap up tomorrow!huge amazing wedge!! this is the third time that price has made it to $4.25. GNPX has been rejected at this price twice before. Third time is winner yes?
Long
55
GNPXA deal I'm going to make opinions on?
Long
$GNPXMomentum to continue
Long
Out of jail cardNo volume, no momentum yet
Long
22
GNPX *ON HIGH ALERT MONDAY PRE MARKET*Same for this one it could gap up over resistance, or actually gap down just have to wait and see. Set alerts. Add to watchlist.
22
Genprex around 100% profit next weeksAbout Genprex Inc Genprex, Inc. operates as a biotechnology company. The Company discovers and develops immunogene therapies for cancer treatment, as well as provides clinical research, gene therapies, consulting, and other related medical services. Genprex serves customers in the United States.
Long
Keep reading
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Stock brokers
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Interactive Brokers
Featured
4.4Very Good
Learn more
TradeStation
4.4Very Good
Learn more
Frequently Asked Questions
The current price of
GNPX
is
2.02
USD
— it has decreased by
1.46
% in the past 24 hours. Watch
Genprex, Inc.
stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on
NASDAQ
exchange
Genprex, Inc.
stocks are traded under the ticker
GNPX
.
GNPX
stock has fallen by
18.22
% compared to the previous week, the month change is a
13.68
% fall, over the last year
Genprex, Inc.
has showed a
93.69
% decrease.
We've gathered analysts' opinions on
Genprex, Inc.
future price: according to them,
GNPX
price has a max estimate of
10.00
USD
and a min estimate of
10.00
USD
. Watch
GNPX chartand read a more detailed
Genprex, Inc. stock forecast: see what analysts think of
Genprex, Inc.
and suggest that you do with its stocks.
GNPX
reached its all-time high on
Apr 30, 2018
with the price of
778.00
USD
, and its all-time low was
2.01
USD
and was reached on
Jun 18, 2024
. View more price dynamics on
GNPX chart.
See other stocks reaching their highest and lowest prices.
GNPX
stock is
5.94
% volatile and has beta coefficient of
4.00
. Track
Genprex, Inc.
stock price on the chart and check out the list of the most volatile stocks — is
Genprex, Inc.
there?
Today
Genprex, Inc.
has the market capitalization of
4.24 M
, it has decreased by
1.22
% over the last week.
Yes, you can track
Genprex, Inc. financialsin yearly and quarterly reports right on TradingView.
Genprex, Inc.
is going to release the next earnings report on
Aug 28, 2024
. Keep track of upcoming events with our Earnings Calendar.
GNPX
earnings for the last quarter are
−3.69
USD
per share, whereas the estimation was
−3.69
USD
resulting in a
% surprise. The estimated earnings for the next quarter are
−2.30
USD
per share. See more details about
Genprex, Inc. earnings.
for the last quarter amounts to
USD
, matching the estimated figure, and no changes in revenue are expected for the next quarter.
GNPX
net income for the last quarter is
−5.97 M
USD
, while the quarter before that showed
−5.93 M
USD
of net income which accounts for
−0.67
% change. Track more
Genprex, Inc. financial statsto get the full picture.
No,
GNPX
doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of
Jun 23, 2024
, the company has
26.00
employees. See our rating of the largest employees — is
Genprex, Inc.
on this list?
Like other stocks,
GNPX
shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade
Genprex, Inc.
stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So
Genprex, Inc.
technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating
Genprex, Inc.
stock shows the sell signal. See more of
Genprex, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
